CONCORD
Invest Now
Start SIP in
CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month + 91.12%
- Over 3 Month + 101.12%
- Over 6 Month + 61.5%
- Over 1 Year + 55.39%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹61.16
+
2.91
(5%)
-
- Bearish Moving Average 0
-
- Bullish Moving Average 0
- 20 Day
- ₹42.97
- 50 Day
- ₹37.10
- 100 Day
- ₹35.23
- 200 Day
- ₹35.15
Resistance and Support
57.5
- R3 61.25
- R2 59.75
- R1 59.00
- S1 56.75
- S2 55.25
- S3 54.50
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-07-03 | Preferential issue of shares | |
2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
2025-05-23 | Audited Results | |
2025-03-17 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Increase in Authorized share Capital. 2. Other business matters. (Revised) |
2025-01-11 | Quarterly Results |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹61 As on 10 July, 2025 | 15:16
The Market Cap of Concord Drugs is ₹61.2 Cr As on 10 July, 2025 | 15:16
The P/E ratio of Concord Drugs is 181.9 As on 10 July, 2025 | 15:16
The PB ratio of Concord Drugs is 1.8 As on 10 July, 2025 | 15:16
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.